STAT

At 83, AIDS activist Larry Kramer isn’t done ripping into his foes in pharma, FDA, and NIH

AIDS activist Larry Kramer has become synonymous with savage attacks on public officials and drug companies. At 83, he has not mellowed one bit.

Over the course of three decades, the name Larry Kramer has become synonymous with the gay rights movement, patient rights — and savage attacks on public officials and drug companies.

Today, with controversy over drug prices and concern over public health funding, we were curious what Kramer had on his mind. We also wondered whether at the age of 83 he has mellowed.

He has not.

“I don’t mince any words,’’ he said.

His take on Francis Collins, director of the National Institutes of Health: “Collins is a wimp.’’

On Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases: “The consummate manipulative bureaucrat who speaks out of too many sides of his mouth.’’

On Gilead,: “Gilead is evil, pure and simple.’’

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Lilly Buying A Plant, A Pfizer Antibiotic, And More
Eli Lilly agreed to acquire a manufacturing facility in Wisconsin from Nexus Pharmaceuticals to produce injectable medicines amid shortages of Mounjaro and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An OptumRx Contract, 340B Dispute Resolution, And More
Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth's OptumRx unit will not be renewed after they expire in June.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.

Related Books & Audiobooks